Mount Hope Mining is preparing for a 9 December ASX listing, focusing on copper and gold exploration in the Cobar Basin, with five high-priority targets and a strategy based on recent geological insights.
Copyright 2024 – Finance News Network
15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
02 Jun 2023 - Falcon Metals Limited (ASX:FAL) Managing Director Tim Markwell discusses progress with the company's gold exploration, touching on key prospects and the results timeline.
28 Aug 2020 - VRX Silica Limited (ASX:VRX) Managing Director, Bruce Maluish provides an update on the company's silica sand projects, the market for silica sand, and timelines.
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
29 Feb 2024 - Mitch Thomas - CFO - Latin Resources (ASX:LRS) is exploring and developing sustainable minerals in Australia and Latin America to provide the planet with environmentally friendly products.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
07 Jun 2021 - Peel Mining Limited (ASX:PEX) Managing Director Rob Tyson talks about the company's projects targeting zinc & copper, drill results, hub and spoke model, and its outlook.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.